Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



PARSHALL B LYNNE Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $45.1268, valued at $451.3k
07/19/2023 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Exercised 1,777 restricted stock units @ $0
Exercised 5,333 restricted stock units @ $0
07/06/2023 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Granted 10,321 options to buy @ $41.08, valued at $424k
Granted 4,677 restricted stock units @ $0
05/18/2023 4 PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $37.89, valued at $378.9k
09/01/2022 4 PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 30,296 shares @ $52.79, valued at $1.6M
Exercised 5,714 options to buy @ $8.75, valued at $50k
Exercised 20,000 options to buy @ $9.45, valued at $189k
Exercised 4,582 options to buy @ $6.82, valued at $31.2k
08/18/2022 4 PARSHALL B LYNNE (Director) has filed a Form 4 on Foghorn Therapeutics Inc.
Txns: Granted 32,000 options to buy @ $16.34, valued at $522.9k
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2022 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,652 shares @ $30.12, valued at $49.8k
Exercised 5,754 restricted stock units @ $0
11/05/2021 4 PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 20,000 shares @ $40, valued at $800k
Sold 4,032 shares @ $40, valued at $161.3k
Sold 4,166 shares @ $40, valued at $166.6k
Sold 2,798 shares @ $40, valued at $111.9k
Exercised 4,166 options to buy @ $6.78, valued at $28.2k
Exercised 2,798 options to buy @ $6.84, valued at $19.1k
Exercised 4,032 options to buy @ $12.4, valued at $50k
Exercised 20,000 options to buy @ $14.25, valued at $285k
10/20/2021 4 PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 1,999 shares @ $35.7343, valued at $71.4k
Sold 8,333 shares @ $35.7343, valued at $297.8k
Exercised 8,333 options to buy @ $6.6, valued at $55k
Exercised 1,999 options to buy @ $6.84, valued at $13.7k
07/19/2021 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Exercised 5,333 restricted stock units @ $0
Exercised 889 restricted stock units @ $0
Exercised 1,778 restricted stock units @ $0
07/06/2021 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Granted 12,000 options to buy @ $40.05, valued at $480.6k
Granted 5,333 restricted stock units @ $0
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 2,741 shares @ $61.28, valued at $168k
Exercised 10,655 restricted stock units @ $0
12/28/2020 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $60, valued at $600k
11/30/2020 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 3,590 shares @ $50.05, valued at $179.7k
Exercised 3,590 options to buy @ $39.87, valued at $143.1k
11/25/2020 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 3,200 shares @ $50.12, valued at $160.4k
Sold 710 shares @ $50.82, valued at $36.1k
Exercised 3,200 options to buy @ $39.87, valued at $127.6k
Exercised 710 options to buy @ $39.87, valued at $28.3k
10/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2020 4 PARSHALL B LYNNE (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.
Txns: Granted 26,400 options to buy @ $16.14, valued at $426.1k
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2020 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 3,905 shares @ $62.06, valued at $242.3k
Exercised 15,136 restricted stock units @ $0
07/03/2019 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Exercised 889 restricted stock units @ $0
Granted 7,110 restricted stock units @ $0
Granted 16,000 options to buy @ $64.8, valued at $1M
06/18/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2019 4 PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 20,000 options to buy @ $10.68, valued at $213.6k
05/01/2019 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 50,000 shares @ $75.0127, valued at $3.8M
Exercised 50,000 options to buy @ $39.87, valued at $2M
03/14/2019 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Sold 8,334 shares @ $75, valued at $625.1k
Exercised 8,334 options to buy @ $39.87, valued at $332.3k
03/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2019 4 PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 6,159 shares @ $58.26, valued at $358.8k
Exercised 20,656 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy